Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Population-based molecular prognosis of breast cancer by transcriptional profiling.

Population-based molecular prognosis of breast cancer by transcriptional profiling. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Population-based molecular prognosis of breast cancer by transcriptional profiling. Abstract Text:

    yan maYan Ma,yong qianYong Qian,liang weiLiang Wei,jame abrahamJame Abraham,xianglin shiXianglin Shi,vincent castranovaVincent Castranova,e james harnerE James Harner,daniel c flynnDaniel C Flynn,lan guoLan Guo,

    PURPOSE: The purpose of this study is to predict breast cancer recurrence and metastases and to identify gene signatures indicative of clinicopathologic characteristics using gene expression patterns derived from cDNA microarray. EXPERIMENTAL DESIGN: Expression profiles of 7,650 genes were investigated on an unselected group of 99 node-negative and node-positive breast cancer patients to identify prognostic gene signature of recurrence and metastases. The identified gene signature was validated on independent 78 patients with primary invasive carcinoma (T(1)/T(2) and N(0)) and on 58 patients with locally advanced breast cancer (T(3)/T(4) and/or N(2)). The gene predictors were identified using a combination of random forests and linear discriminant analysis function. RESULTS: This study identified a new 28-gene signature that achieved highly accurate disease-free survival and overall survival (both at P < 0.001, time-dependent receiver operating characteristic analysis) in individual breast cancer patients. Patients categorized into high-risk, intermediate-risk, and low-risk groups had distinct disease-free survival (P < 0.005, Kaplan-Meier analysis, log-rank test) in three patient cohorts. A strong association (P < 0.05) was identified between risk groups and tumor size, tumor grade, estrogen receptor and progesterone receptor status, and HER2/neu overexpression in the studied cohorts. We also identified 14-gene predictors of nodal status and 9-gene predictors of tumor grade. CONCLUSIONS: This study has established a population-based approach to predicting breast cancer outcomes at the individual level exclusively based on gene expression patterns. The 28-gene recurrence signature has been validated as quantifying the probability of recurrence and metastases in patients with heterogeneous histology and disease stage.

    Population-based molecular prognosis of breast cancer by transcriptional profiling. Publishing Authors By Initials

    y maY Ma,y qianY Qian,l weiL Wei,j abrahamJ Abraham,x shiX Shi,v castranovaV Castranova,ej harnerEJ Harner,dc flynnDC Flynn,l guoL Guo,

    For similar roc curve research abstracts see: roc curve research

    PUBMED ID PMID:

    MEDLINE DATE:

    Population-based molecular prognosis of breast cancer by transcriptional profiling. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Clinical cancer research : an official journal of

    VOLUME: 13

    Page Numbers: 2014-22

    Journal Abbreviation: Clin. Cancer Res.

    ISSN: 1078-0432

    DAY: 1

    MONTH: Apr

    YEAR: 2007

    Population-based molecular prognosis of breast cancer by transcriptional profiling. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 9502500

    Population-based molecular prognosis of breast cancer by transcriptional profiling. Keywords Mesh Terms:

    KEYWORDS: ROC Curve

    MESH TERMS: genetics

    Chemical & Substance for Abstract: Population-based molecular prognosis of breast cancer by transcriptional profiling. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Population-based molecular prognosis of breast cancer by transcriptional profiling.

    AFFILIATION: Mary Babb Randolph Cancer Center, Department of Statistics, Division of Hematology, West Virginia University, Morgantown, WV 26506-9300, USA.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NCRR

    GRANT: P20 RR16440-03

    ACRONYM: RR

    MEDLINETA: Clin Cancer Res

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Population-based molecular prognosis of breast cancer by transcriptional profiling Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News